All Work

Austin Smith

Josh Brown: Biotech growth stocks immune to disruption risk

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap biotech: “These are growth stocks where you don’t have to worry about disruption. They’re breaking…

Austin Smith · 6 months ago

SCM’s 16.5% Yield Looks Tempting, But the Dividend Was Just Slashed

Stellus Capital Investment Corporation (NYSE:SCM) is a business development company providing debt and equity financing to private middle-market businesses, earning income primarily through interest on senior secured loans and subordinated debt. For retirees drawn…

Austin Smith · 6 months ago

I’d Own VGT for the Next 30 Years, And Never Look Back

VGT is a stock worth owning for decades because it gives you low-cost, diversified exposure to the companies that will define how the global economy operates — not as a speculative bet, but as…

Austin Smith · 6 months ago